Characteristics of Cervical Pre-Cancerous Lesions at Sanjiwani General Hospital in January-December 2022

Pande Made Ngurah Geriawan, Pande Made Angger Parameswara
{"title":"Characteristics of Cervical Pre-Cancerous Lesions at Sanjiwani General Hospital in January-December 2022","authors":"Pande Made Ngurah Geriawan, Pande Made Angger Parameswara","doi":"10.24018/ejmed.2023.5.3.1687","DOIUrl":null,"url":null,"abstract":"\nPre-cancerous lesions are cell changes that start on the surface of the cervix near the squamocolumnar junction (SCJ). Cervical cancer can be prevented through early identification and treatment. These pre-cancerous lesions can be identified through methods such as pap smears, visual inspection with acetic acid (VIA), and human papillomavirus (HPV) DNA tests. This study aims to determine the characteristics of cervical pre-cancerous lesions at Sanjiwani General Hospital. This is a descriptive observational study design with a cross-sectional approach at Sanjiwani General Hospital from January to December 2022. The inclusion criteria were patients who had pap smear screening and were recorded entirely in the examination data archive at the Anatomical Pathology Laboratory of Sanjiwani General Hospital in 2022. The exclusion criteria were Pap smear results with inadequate pap smears to be evaluated. The result was obtained from secondary data from patient medical records, determined by the total sampling technique, and will be processed using the IBM SPSS Statistics Version 26 application. In total, 35 samples met the research criteria. All samples (100%) showed positive findings on the VIA test. The most found on the pap smear screening was 15 samples (42.9%) with NILM and followed in succession by eight samples (22.9%) with ASC-US, seven samples (20%) with ASC-H, three samples (8.5%) LSIL, and two samples (5.7%) with findings of HSIL. Most patients with Pap smears at Sanjiwani General Hospital in 2022 will be in the age group of 41-50. Based on obstetric and gynecological history, most respondents had parity ≥ 3, age at sexual intercourse ≥20 years, number of sexual partners was only one, and had not experienced menopause. Most patients use hormonal contraception, have no family history of cervical cancer, and have never been vaccinated or screened for HPV. Most of the pap smear findings were NILM, with the most abnormalities found being ASCUS.\n","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"55 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medical and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24018/ejmed.2023.5.3.1687","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pre-cancerous lesions are cell changes that start on the surface of the cervix near the squamocolumnar junction (SCJ). Cervical cancer can be prevented through early identification and treatment. These pre-cancerous lesions can be identified through methods such as pap smears, visual inspection with acetic acid (VIA), and human papillomavirus (HPV) DNA tests. This study aims to determine the characteristics of cervical pre-cancerous lesions at Sanjiwani General Hospital. This is a descriptive observational study design with a cross-sectional approach at Sanjiwani General Hospital from January to December 2022. The inclusion criteria were patients who had pap smear screening and were recorded entirely in the examination data archive at the Anatomical Pathology Laboratory of Sanjiwani General Hospital in 2022. The exclusion criteria were Pap smear results with inadequate pap smears to be evaluated. The result was obtained from secondary data from patient medical records, determined by the total sampling technique, and will be processed using the IBM SPSS Statistics Version 26 application. In total, 35 samples met the research criteria. All samples (100%) showed positive findings on the VIA test. The most found on the pap smear screening was 15 samples (42.9%) with NILM and followed in succession by eight samples (22.9%) with ASC-US, seven samples (20%) with ASC-H, three samples (8.5%) LSIL, and two samples (5.7%) with findings of HSIL. Most patients with Pap smears at Sanjiwani General Hospital in 2022 will be in the age group of 41-50. Based on obstetric and gynecological history, most respondents had parity ≥ 3, age at sexual intercourse ≥20 years, number of sexual partners was only one, and had not experienced menopause. Most patients use hormonal contraception, have no family history of cervical cancer, and have never been vaccinated or screened for HPV. Most of the pap smear findings were NILM, with the most abnormalities found being ASCUS.
Sanjiwani总医院2022年1 - 12月宫颈癌前病变的特点
癌前病变是开始于宫颈表面鳞状柱连接处(SCJ)的细胞变化。子宫颈癌可以通过早期发现和治疗来预防。这些癌前病变可以通过巴氏涂片、醋酸目视检查(VIA)和人乳头瘤病毒(HPV) DNA检测等方法来识别。本研究旨在确定三吉瓦尼总医院宫颈癌前病变的特点。这是一项描述性观察性研究设计,采用横断面方法,于2022年1月至12月在Sanjiwani总医院进行。纳入标准是接受子宫颈抹片检查的患者,并于2022年全部记录在Sanjiwani总医院解剖病理实验室的检查数据档案中。排除标准为子宫颈抹片检查结果不充分的子宫颈抹片检查结果。结果来自患者医疗记录的辅助数据,由总抽样技术确定,并将使用IBM SPSS Statistics Version 26应用程序进行处理。总共有35个样本符合研究标准。所有样本(100%)在VIA测试中显示阳性结果。在巴氏涂片筛查中发现最多的是NILM 15例(42.9%),其次是ASC-US 8例(22.9%),ASC-H 7例(20%),LSIL 3例(8.5%),HSIL 2例(5.7%)。到2022年,Sanjiwani总医院接受子宫颈抹片检查的大多数患者年龄将在41-50岁之间。根据妇产科病史,大多数调查对象产次≥3次,性交年龄≥20岁,性伴侣数为1次,未绝经。大多数患者使用激素避孕,没有宫颈癌家族史,从未接种过HPV疫苗或进行过HPV筛查。大多数子宫颈抹片检查结果为NILM,大多数异常发现为ASCUS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信